- Home
- DXLG vs FORA Comparison
DXLG vs FORA Comparison
Compare DXLG & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DXLG | FORA |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 69.4M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | DXLG | FORA |
|---|---|---|
| Price | $1.19 | $2.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 223.2K | 36.0K |
| Earning Date | 12-11-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $442,120,000.00 | $28,106,911.00 |
| Revenue This Year | N/A | $47.82 |
| Revenue Next Year | $3.95 | $10.11 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 37.47 |
| 52 Week Low | $0.88 | $1.64 |
| 52 Week High | $3.10 | $4.03 |
Technical Indicators
Market Signals| Indicator | DXLG | FORA |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 45.69 |
| Support Level | $1.01 | $2.11 |
| Resistance Level | $1.58 | $2.20 |
| Average True Range (ATR) | 0.15 | 0.07 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 35.77 | 50.00 |
Price Performance
Historical ComparisonAbout DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.